4//SEC Filing
Chaudhary Kleem 4
Accession 0000899243-21-008619
CIK 0001651431other
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:15 PM ET
Size
7.1 KB
Accession
0000899243-21-008619
Insider Transaction Report
Form 4
Chaudhary Kleem
Chief Business Officer
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2021-02-26−2,000→ 97,508 totalExercise: $2.62Exp: 2029-11-13→ Common Stock (2,000 underlying) - Exercise/Conversion
Common Stock
2021-02-26$2.62/sh+2,000$5,240→ 8,000 total
Footnotes (1)
- [F1]25% of the shares subject to such option vested and became exercisable on November 1, 2020 with the remainder to vest in substantially equal monthly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
Documents
Issuer
Checkmate Pharmaceuticals, Inc.
CIK 0001651431
Entity typeother
Related Parties
1- filerCIK 0001817587
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Mar 1, 4:15 PM ET
- Size
- 7.1 KB